Cardiovascular disease (CVD), including heart disease and stroke, is the world’s leading cause of death, claiming 17.5 million lives annually, and by 2030 this figure is expected to rise to 23 million.
On September 19 2018, the ‘Salt Substitute and Stroke Study (SSaSS) Annual Meeting 2018’ was held in Qingdao. Over 50 participants joined the meeting to review progress on the study and exchange experiences. Those who attended the meeting included Principal Investigators from China and Australia, Project Coordinators from provincial study centers, and government officials from local Disease Control and Prevention Centers and Public Health Systems.
On September 18, 2018, Taikang Pension Insurance Co., Ltd. and The George Institute for Global Health signed a Memorandum of Understanding (MoU) for strategic cooperation. Liu Hongbo, Deputy General Manager of Taikang Pension, and Professor Anushka Patel, Chief Scientist of The George Institute for Global Health, signed the MoU on behalf of each party.
On 8 June, 2018, the INTERACT3 (INTEnsive care bundle with blood pressure reduction in Acute Cerebral hemorrhage Trial) study’s first investigator meeting was held successfully in Chengdu. Participants included principal investigators from Australia and China, and more than 160 doctors from 85 participating hospital sites in China.